SWM
BMRN icon

Spire Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Spire Wealth Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-28
Closed -$1.98K – 2398
2025
Q1 		$1.98K Sell
28
-10
-26% -$673 ﹤0.01% 2279
2024
Q4 		$2.5K Sell
38
-115
-75% -$7.7K ﹤0.01% 2206
2024
Q3 		$10.8K Sell
153
-7
-4% -$585 ﹤0.01% 1605
2024
Q2 		$13.2K Buy
160
+77
+93% +$6.41K ﹤0.01% 1563
2024
Q1 		$7.25K Sell
83
-3
-3% -$269 ﹤0.01% 1817
2023
Q4 		$7.93K Hold
86
– – ﹤0.01% 1816
2023
Q3 		$7.61K Buy
86
+11
+15% +$979 ﹤0.01% 1813
2023
Q2 		$6.5K Sell
75
-26,289
-100% -$2.47M ﹤0.01% 1937
2023
Q1 		$2.56M Buy
26,364
+26,236
+20,497% +$2.72M 0.1% 200
2022
Q4 		$13K Hold
128
– – ﹤0.01% 1512
2022
Q3 		$11K Hold
128
– – ﹤0.01% 1528
2022
Q2 		$11K Sell
128
-75
-37% -$5.97K ﹤0.01% 1869
2022
Q1 		$16K Sell
203
-174
-46% -$14.6K ﹤0.01% 1886
2021
Q4 		$33K Buy
377
+141
+60% +$11.6K ﹤0.01% 1906
2021
Q3 		$18K Buy
236
+36
+18% +$2.84K ﹤0.01% 1885
2021
Q2 		$17K Sell
200
-389
-66% -$30.8K ﹤0.01% 1932
2021
Q1 		$44K Buy
+589
New +$48.1K ﹤0.01% 1784

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Spire Wealth Management's BMRN Position: Q2 2025 in Review

Spire Wealth Management sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2025, closing a stake of 28 shares — an estimated $1.98K sold.

Spire Wealth Management first reported a position in BMRN in Q1 2021 and held it in 17 quarters. The position peaked at $2.56M in Q1 2023. 581 funds tracked by Wall St. Rank hold BMRN as of Q2 2025.

  • Spire Wealth Management reported no remaining BioMarin Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Spire Wealth Management sold 28 BioMarin Pharmaceuticals shares in Q2 2025, an estimated $1.98K.
  • Spire Wealth Management first reported a position in BioMarin Pharmaceuticals in Q1 2021 and held it in 17 quarters.
  • Spire Wealth Management's BioMarin Pharmaceuticals position peaked at $2.56M in Q1 2023.
  • 581 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2025.

Based on Spire Wealth Management's 13F filing for Q2 2025, filed 4 Aug 2025.